Distinguishing between immune-related pneumonitis and disease progression in advanced Non Small Cell Lung Cancer treated with PD-1 inhibitors: Can serum tumour markers have a role?

Eur J Cancer. 2018 May:95:127-129. doi: 10.1016/j.ejca.2018.02.020. Epub 2018 Mar 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma, Non-Small-Cell Lung*
  • Cryptogenic Organizing Pneumonia
  • Disease Progression
  • Humans
  • Lung Neoplasms
  • Nivolumab*
  • Pneumonia
  • Programmed Cell Death 1 Receptor

Substances

  • Biomarkers, Tumor
  • Programmed Cell Death 1 Receptor
  • Nivolumab